SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-017151
Filing Date
2019-03-25
Accepted
2019-03-25 16:45:56
Documents
2
Period of Report
2019-03-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-7209_18k.htm 8-K 21533
2 EX-99.1 a19-7209_1ex99d1.htm EX-99.1 15193
  Complete submission text file 0001104659-19-017151.txt   37788
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 19703152
SIC: 2834 Pharmaceutical Preparations